Publications by authors named "Maissa El-Raziky"

Claim this Profile
R
Role of IL-6, TNF-α and VCAM-1 as predictors of renal impairment in patients with spontaneous bacterial peritonitis.
Maissa El Raziky, Mennatallah Rashwan, Hend Hamed Tamim, Shimaa Afify, Rania M Lithy

Trans R Soc Trop Med Hyg· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of dapagliflozin compared to pioglitazone in diabetic and non-diabetic patients with non-alcoholic steatohepatitis: A randomized clinical trial.
Mona S Abdel Monem, Abdulmoneim Adel, Maggie M Abbassi, Doaa H Abdelaziz, Mohamed Hassany

Clin Res Hepatol Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of IBD disease activity by Interleukin-6 and serum amyloid A in relation with fecal calprotectin and endoscopic indices.
Ahmed Bahaa, Tamer Elbaz, Hesham Elmakhzangy, Mohammed Shehata, Dalia Abd El-Kareem

Arab J Gastroenterol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease.
Mohammad El-Sayed, Magdy Elserafy, Maissa El Raziky, Wafaa Elakel, Yasmin Saad

Arab J Gastroenterol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retreatment of chronic hepatitis C virus genotype-4 patients after non-structural protein 5A inhibitors' failure: efficacy and safety of different regimens.
Hisham El-Khayat, Enas M Kamal, Hani Mahmoud, Ahmed Gomaa, Bassel Ebeid

Eur J Gastroenterol Hepatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus infection and global kidney health: the consensus proceedings of the International Federation of Kidney Foundations.
Gamal Saadi, Kamyar Kalantar-Zadeh, Piero Almasio, Gloria Ashuntantang, Rashad Barsoum

Afr J Nephrol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study.
Samar K Darweesh, Kadry Elsaeed, Heba Omar, Maissa El Raziky, Wafaa Elakel

Expert Rev Gastroenterol Hepatol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience.
Aisha Elsharkawy, Maissa El-Raziky, Wafaa El-Akel, Kadry El-Saeed, Rasha Eletreby

J Hepatol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing Regimens.
Maissa El-Raziky, Marwa Khairy, Ahmed Fouad, Ahmed Salama, Aisha Elsharkawy

J Interferon Cytokine Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of old Schistosomiasis infection on the use of transient elastography (Fibroscan) for staging of fibrosis in chronic HCV patients.
Iman Ramzy, Aisha Elsharkawy, Rabab Fouad, Hanan Abdel Hafez, Maissa El Raziky

Acta Trop· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Dose of Silymarin in Patients with Decompensated Liver Disease: A Randomized Controlled Trial.
Waleed Fouad Fathalah, Mohamed AbdAllah Abdel Aziz, Neveen Helmy Abou El Soud, Maissa El Said El Raziky

J Interferon Cytokine Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C.
Maissa El Raziky, Naglaa A Zayed, Amin Abdel Baki, Shimaa A Mansour, Rasha M H Shahin

J Med Virol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of vitamin D binding protein polymorphisms with response to therapy in Egyptian chronic hepatitis C patients.
Ahmed Mohamed Kamel, Samar Farghali Farid, Ahmed Sherif Attia, Maissa El Raziky

J Infect Dev Ctries· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon.
Aisha Elsharkawy, Shereen Abdel Alem, Rabab Fouad, Maissa El Raziky, Wafaa El Akel

J Gastroenterol Hepatol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4.
Gamal Esmat, Tamer Elbaz, Maissa El Raziky, Asmaa Gomaa, Mahmoud Abouelkhair

J Hepatol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular Carcinoma.
Lamiaa A Mansour, Maissa El Raziky, Amal A Mohamed, Enas H Mahmoud, Sherif Hamdy

Asian Pac J Cancer Prev· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Real life Egyptian experience of efficacy / safety of Simeprevir\ Sofosbuvir in HCV genotype IV.
Rasha Eletreby, Wafaa Elakel, Maissa El Raziky, Gamal Esmat

Liver Int· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.
Rasha Eletreby, Wafaa Elakel, Mohamed Said, Mohamed El Kassas, Sameh Seif

Liver Int· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory and activated effector T cells in chronic hepatitis C virus: Relation to autoimmunity.
Hanan Fouad, Maissa El Raziky, Eman Medhat Hassan, Ghada Mahmoud Abdel Aziz, Samar K Darweesh

World J Hepatol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence of HCV among Cairo University students in Egypt.
Gamal Esmat, Maissa El Raziky, Mohammed M Nabeel, Rabab Maher, Zeinab Zakaria

J Med Virol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Virological Response in 3,235 Chronic HCV Egyptian Patients Treated with Peginterferon Alpha-2a Compared with Peginterferon Alpha-2b Using Statistical Methods and Data Mining Techniques.
Maissa El Raziky, Waleed Fouad Fathalah, Zeinab Zakaria, Hadeel Gamal Eldeen, Amr Abul-Fotouh

J Interferon Cytokine Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.
Maissa El Raziky, Aisha Elsharkawy, Salma E Said, Sahar Abdelatty, Wafaa El Akel

J Interferon Cytokine Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.
Gamal Esmat, Maissa El Raziky, Aisha Elsharkawy, Dina Sabry, Mohamed Hassany

J Interferon Cytokine Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is rs8099917 polymorphism of IL-28B gene a good predictor of response to therapy of HCV than rs12979860? An Egyptian study.
Olfat Shaker, Amal Rashad, Ghada Abd El Aziz, Maissa El Raziky

Cell Biochem Biophys· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, biochemical and pathological profiles of 5464 Egyptian chronic hepatitis C-infected patients.
Mahasen Mabrouk, Maissa El-Raziky, Naglaa Zayed, Rabab Salama, Wafaa El-Akel

Hepatogastroenterology· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis